⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14044127 | 0.77 | — | — | |
| SCHEMBL8339076 | 0.74 | — | — | |
| SCHEMBL5901327 | 0.72 | — | — | |
| SCHEMBL9226904 | 0.72 | — | — | |
| SCHEMBL31077525 | 0.72 | — | — | |
| SCHEMBL5901257 | 0.72 | — | — | |
| SCHEMBL11098106 | 0.72 | — | — | |
| SCHEMBL1470126 | 0.71 | — | — | |
| SCHEMBL13718649 | 0.71 | — | — | |
| SCHEMBL17390952 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333424-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2025-10-30 | — | — | US | disclosed |
| WO-2025076523-A1 | RAS INHIBITORS AND METHODS OF USE THEREOF | KESTREL THERAPEUTICS, INC. (US) | 2025-04-10 | — | — | WO | disclosed |
| WO-2025068951-A1 | COMPLEMENT FACTOR B INHIBITORS AND USES THEREOF | NOVARTIS AG (CH) | 2025-04-03 | — | — | WO | disclosed |
| US-20250042927-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2025-02-06 | — | — | US | disclosed |
| CN-119306766-A | Organic electroluminescent material and device | 环球展览公司 | 2025-01-14 | — | — | CN | disclosed |
| US-11374260-B2 | Nonaqueous electrolyte compositions comprising fluorinated sulfones | SYENSQO SA (BE) | 2022-06-28 | — | — | US | disclosed |
| WO-2020198351-A1 | SELECTIVE FOXO INHIBITORS FOR TREATMENT OF DIABETES AND OTHER DISORDERS RELATED TO IMPAIRED PANCREATIC FUNCTION | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2020-10-01 | — | — | WO | disclosed |
| US-9187446-B2 | Antibacterial agents: sidechainfluorinated myxopyronin derivatives | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2015-11-17 | — | — | US | disclosed |
| US-20150051275-A1 | ANTIBACTERIAL AGENTS: SIDECHAINFLUORINATED MYXOPYRONIN DERIVATIVES | HOWARD HUGHES MEDICAL INSTITUTE | 2015-02-19 | — | — | US | disclosed |
| EP-2658847-A1 | 2 - (2 - PHENYLETHENYL) - 1, 3 -BENZOTHIAZINE DERIVATIVES USEFUL FOR THE TREATMENT OF CANCER | Novotyr Therapeutics Ltd. (IL) | 2013-11-06 | — | — | EP | disclosed |
| US-6593493-B1 | 2-(Carboxy(unsaturated)alkyl)-1-(haloalkoxy)benzene derivatives; retinoid X receptors; cardiovascular, skin, eating and vision disorders; anticarcinogenic agents; non-insulin-dependent diabetes | LIGAND PHARMACEUTICALS, INC. | 2003-07-15 | — | — | US | disclosed |
| US-4087432-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1978-05-02 | — | — | US | disclosed |
| US-4082534-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1978-04-04 | — | — | US | disclosed |
| US-4054573-A | Certain ethers of certain di and trihalo-1-hydroxy-2-(fluoroalkyl)1H-imidazo(4,5-b)pyridine derivatives | ELI LILLY AND COMPANY (US) | 1977-10-18 | — | — | US | disclosed |
| US-4042593-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1977-08-16 | — | — | US | disclosed |
| US-4000145-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3968116-A | HERBICIDE | ELI LILLY AND COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
| US-3963734-A | HERBICIDES, HERBICIDE INTERMEDIATES | ELI LILLY AND COMPANY (US) | 1976-06-15 | — | — | US | disclosed |
| US-3961937-A | Esters of 1-hydroxy-1H-imidazo-(4,5-b)-pyridines as herbicides | ELI LILLY AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3932428-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1976-01-13 | — | — | US | disclosed |